Nursing Elites

1. What is a type of heart disease that involves the thickening or stiffening of the heart muscle, reducing its ability to pump blood?

• A. Hypertrophic cardiomyopathy
• B. Dilated cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Arrhythmia

Correct answer: A

Rationale: Hypertrophic cardiomyopathy is a type of heart disease characterized by the thickening or stiffening of the heart muscle, leading to a reduced ability to pump blood. This condition is different from dilated cardiomyopathy (choice B), which involves the enlargement and weakening of the heart chambers. Restrictive cardiomyopathy (choice C) is characterized by the stiffening of the heart muscle, affecting its ability to fill with blood properly. Arrhythmia (choice D) refers to abnormal heart rhythms and is not specifically related to thickening or stiffening of the heart muscle, as seen in hypertrophic cardiomyopathy.

2. What procedure is used to remove fluid from the pleural space to help a patient breathe more easily?

• A. Thoracentesis
• B. Bronchoscopy
• C. Echocardiogram
• D. CT scan

Correct answer: A

Rationale: Thoracentesis is the correct answer. It is a procedure where a needle is inserted into the pleural space to drain fluid, relieving pressure and helping the patient breathe more easily. Bronchoscopy (choice B) is a procedure used to examine the airways, not to drain fluid. An echocardiogram (choice C) is an imaging test to assess the heart's structure and function, not related to draining pleural fluid. A CT scan (choice D) is a cross-sectional imaging test that provides detailed pictures of the inside of the body, not used for draining pleural fluid.

3. This medication type is used to relax and widen blood vessels, improving blood flow and reducing blood pressure.

• A. Vasodilator
• B. Anticoagulant
• C. Diuretic
• D. Beta-blocker

Correct answer: A

Rationale: The correct answer is A: Vasodilator. Vasodilators are medications that work by relaxing and widening blood vessels, which improves blood flow and reduces blood pressure. They are commonly used in the treatment of heart conditions. Anticoagulants (choice B) are medications that prevent blood clot formation, diuretics (choice C) increase urine production to reduce fluid retention, and beta-blockers (choice D) reduce heart rate and workload on the heart. These mechanisms differ from the action of vasodilators.

4. What is a condition where the walls of the arteries in the lungs become thickened and stiff, leading to increased blood pressure in the pulmonary arteries?

• A. Pulmonary hypertension
• B. Pulmonary fibrosis
• C. Pulmonary embolism
• D. Pulmonary edema

Correct answer: A

Rationale: Pulmonary hypertension is a condition characterized by the thickening and stiffening of the arteries in the lungs, resulting in elevated blood pressure in the pulmonary arteries. This condition is distinct from the other choices provided. Pulmonary fibrosis involves scarring of lung tissue, pulmonary embolism is a blockage in the pulmonary artery, and pulmonary edema is the accumulation of fluid in the lungs.

5. Which neurotransmitter released by the parasympathetic nervous system can decrease heart rate?

• A. Acetylcholine
• B. Norepinephrine
• C. Dopamine
• D. Serotonin

Correct answer: A

Rationale: Acetylcholine is the correct answer. It is a neurotransmitter released by the parasympathetic nervous system that can decrease heart rate. Norepinephrine, dopamine, and serotonin are neurotransmitters that usually have different effects on the body and are not specifically associated with decreasing heart rate. Norepinephrine, for example, is often related to the fight-or-flight response and can increase heart rate.

Similar Questions